Pheochromocytoma laboratory findings

Revision as of 14:48, 2 September 2015 by Ahmad Al Maradni (talk | contribs)
Jump to navigation Jump to search

Pheochromocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pheochromocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pheochromocytoma laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pheochromocytoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pheochromocytoma laboratory findings

CDC on Pheochromocytoma laboratory findings

Pheochromocytoma laboratory findings in the news

Blogs on Pheochromocytoma laboratory findings

Directions to Hospitals Treating Pheochromocytoma

Risk calculators and risk factors for Pheochromocytoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings consistent with the diagnosis of pheochromocytoma include elevated catecholamines and metanephrine levels

Laboratory Findings

The diagnosis can be established by measuring catecholamines and metanephrines in plasma or through a 24-hour urine collection. Urinary vanillyl mandelic acid may be elevated.

References

Template:WikiDoc Sources